Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
20.26
+0.14 (0.70%)
Aug 15, 2025, 3:00 PM CST
SHA:600161 Market Cap
SHA:600161 has a market cap or net worth of 40.06 billion as of August 15, 2025. Its market cap has decreased by -21.41% in one year.
Market Cap
40.06B
Enterprise Value
41.40B
Revenue
6.30B
Ranking
n/a
PE Ratio
27.74
Stock Price
20.26
Market Cap Chart
Since March 8, 2000, SHA:600161's market cap has increased from 3.95B to 40.06B, an increase of 914.85%. That is a compound annual growth rate of 9.53%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 15, 2025 | 40.06B | -1.17% |
Dec 31, 2024 | 40.54B | -20.49% |
Dec 29, 2023 | 50.98B | 30.38% |
Dec 30, 2022 | 39.10B | -1.67% |
Dec 31, 2021 | 39.77B | -23.98% |
Dec 31, 2020 | 52.31B | 79.10% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 419.19B |
WuXi AppTec | 287.87B |
Shenzhen Mindray Bio-Medical Electronics | 282.32B |
Sichuan Biokin Pharmaceutical | 126.19B |
Zhangzhou Pientzehuang Pharmaceutical., | 121.83B |
Aier Eye Hospital Group | 120.01B |
Shanghai United Imaging Healthcare | 104.90B |
Yunnan Baiyao Group Co.,Ltd | 99.92B |